Mutational Spectrum of Barrett’s Stem Cells Suggests Paths to Initiation of a Precancerous Lesion

Yusuke Yamamoto,Xia Wang,Denis Bertrand,Florian Kern,Ting Zhang,Marcin Duleba,Supriya Srivastava,Chiea Chuen Khor,Yuanyu Hu,Lane H. Wilson,Hagen Blaszyk,Daniil Rolshud,Ming Teh,Jianjun Liu,Brooke E. Howitt,Matthew Vincent,Christopher P. Crum,Niranjan Nagarajan,Khek Yu Ho,Frank McKeon,Wa Xian

DOI: https://doi.org/10.1038/ncomms10380

IF: 16.6

2016-01-01

Nature Communications

Abstract:The precancerous lesion known as Barrett’s oesophagus can evolve to oesophageal adenocarcinoma in decades-long processes of regenerative growth. Here we report the isolation and propagation of distinct, patient-matched stem cells of Barrett’s, gastric and oesophageal epithelia that yield divergent tumour types following in vitro transformation and xenografting. Genomic analyses reveal a broad mutational spectrum unique to Barrett’s stem cells that likely reflects their risk for oncogenesis. Remarkably, 25% of cases show no cancer-related genomic changes, suggesting that Barrett’s initiates without driver mutations. Most cases, however, sustain patterns of deletions almost identical to adenocarcinoma though tumour-associated gene amplifications were absent. Notably, those suspected of low-grade dysplasia have p53 mutations or undergo amplifications of proto-oncogenes and receptor tyrosine kinases, implicating these events in lethal transitions. Our findings suggest paths for the initiation and progression of Barrett’s and define a discrete stem cell underlying its regenerative growth whose eradication could prevent oesophageal adenocarcinoma.